Simble Solutions Limited– NanoSensor Development Update
Simble Solutions (ASX: SIS) is advancing its structured development program for its exclusively licensed NanoSensor Technology, following its December 2025 acquisition of Next Nano Pty Ltd. The program leverages extensive laboratory data, prototype devices, and characterisation work to evaluate the platform’s commercial potential across multiple high-value applications, including gas detection, UV and wavelength sensing, e-skin, flexible electronics, multi-sensor integration, and defence and security applications.
The NanoSensor platform combines molecular-level sensitivity, sub-millimetre form factor, ultra-low power consumption, and integration flexibility, addressing structural limitations of conventional sensors. Target markets include Industrial IoT (US$1.69 trillion by 2030), CBRNe defence sensing (US$30 billion by 2033), and wearable medical devices (US$139 billion by 2035). Development follows a five-stage framework from sensor fabrication to customer trials, ensuring transparency and systematic assessment of commercial viability. Successful commercialization could enable Simble-branded sensor devices, enhancing product economics and technical integration. Initial outcomes from advanced applications are expected in the near term, guiding future prioritization of high-potential pathways.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Simble Solutions Limited– NanoSensor Development Update
Simble Solutions (ASX: SIS) is advancing its structured development program for its exclusively licensed NanoSensor Technology, following its December 2025 acquisition of Next Nano Pty Ltd. The program leverages extensive laboratory data, prototype devices, and characterisation work to evaluate the platform’s commercial potential across multiple high-value applications, including gas detection, UV and wavelength sensing, e-skin, flexible electronics, multi-sensor integration, and defence and security applications.
The NanoSensor platform combines molecular-level sensitivity, sub-millimetre form factor, ultra-low power consumption, and integration flexibility, addressing structural limitations of conventional sensors. Target markets include Industrial IoT (US$1.69 trillion by 2030), CBRNe defence sensing (US$30 billion by 2033), and wearable medical devices (US$139 billion by 2035). Development follows a five-stage framework from sensor fabrication to customer trials, ensuring transparency and systematic assessment of commercial viability. Successful commercialization could enable Simble-branded sensor devices, enhancing product economics and technical integration. Initial outcomes from advanced applications are expected in the near term, guiding future prioritization of high-potential pathways.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au